Thematic

Causal claim

Intra Cellular Therapies Antipsychotic Treatment

Intra Cellular Therapies enables Antipsychotic Treatment.

The two move together: more cause, more effect. The map scores it at 27% confidence, weighed from 1 article.

How it works

Intra-Cellular Therapies markets lumateperone (Caplyta), an atypical antipsychotic indicated for bipolar depression.

The evidence

Where it sits

What feeds it

Nothing upstream on the map yet.

What it drives

See it on the live map →